The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 ...

Automated insulin delivery (AID) systems are transforming how people with Type 1 diabetes manage their condition, offering tighter glucose control and more freedom in daily life. Yet, access to this ...

BRIDGEWATER, N.J., June 25, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device—a simple, all-in-one, ...

Automated insulin delivery (AID) systems, also known as hybrid closed loop systems, are changing the way type 1 diabetes is managed. These systems, which combine an insulin pump with a continuous ...

The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...

Please provide your email address to receive an email when new articles are posted on . The MiniMed Go app received FDA 510(k) clearance for people with type 1 or type 2 diabetes requiring insulin.

Omnipod 5 is the first AID system cleared for type 1 and type 2 diabetes management. Insulet’s Omnipod ® 5 Automated Insulin Delivery (AID) System has been cleared by the Food and Drug Administration ...